Cilag (Pevaryl Brand Portfolio European Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Cilag (Pevaryl Brand Portfolio European Rights) General Information

Description

Antifungal medication brand portfolio Pevaryl in Europe.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Distributors (Healthcare)
Acquirer
Corporate Office
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cilag (Pevaryl Brand Portfolio European Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cilag (Pevaryl Brand Portfolio European Rights)‘s full profile, request access.

Request a free trial

Cilag (Pevaryl Brand Portfolio European Rights) Patents

Cilag (Pevaryl Brand Portfolio European Rights) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-1700122-U Rubber by puncturing closure for infusion. Inactive 19-Jun-1954

Cilag (Pevaryl Brand Portfolio European Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cilag (Pevaryl Brand Portfolio European Rights)‘s full profile, request access.

Request a free trial

Cilag (Pevaryl Brand Portfolio European Rights) FAQs

  • Where is Cilag (Pevaryl Brand Portfolio European Rights) headquartered?

    Cilag (Pevaryl Brand Portfolio European Rights) is headquartered in Switzerland.

  • What industry is Cilag (Pevaryl Brand Portfolio European Rights) in?

    Cilag (Pevaryl Brand Portfolio European Rights)’s primary industry is Buildings and Property.

  • Is Cilag (Pevaryl Brand Portfolio European Rights) a private or public company?

    Cilag (Pevaryl Brand Portfolio European Rights) is a Private company.

  • What is the current valuation of Cilag (Pevaryl Brand Portfolio European Rights)?

    The current valuation of Cilag (Pevaryl Brand Portfolio European Rights) is .

  • What is Cilag (Pevaryl Brand Portfolio European Rights)’s current revenue?

    The current revenue for Cilag (Pevaryl Brand Portfolio European Rights) is .

  • Who are Cilag (Pevaryl Brand Portfolio European Rights)’s investors?

    Cilag has invested in Cilag (Pevaryl Brand Portfolio European Rights).

  • When was Cilag (Pevaryl Brand Portfolio European Rights) acquired?

    Cilag (Pevaryl Brand Portfolio European Rights) was acquired on 08-May-2020.

  • Who acquired Cilag (Pevaryl Brand Portfolio European Rights)?

    Cilag (Pevaryl Brand Portfolio European Rights) was acquired by Karo Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »